Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-13

Clinical Trial Update: Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ubiquinone (Coenzyme Q10) and a combined antioxidant therapy for non-proliferative diabetic retinopathy has completed, repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined Antioxidant Therapy
  • Ubiquinone (Coenzyme Q10) (ubiquinone)

Snippet

Sponsor: University of Guadalajara | Conditions: Non-proliferative Diabetic Retinopathy, Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED